The HOME IV working meeting was held in Malmö, Sweden on 23rd - 24th April 2015 and focussed on moving towards consensus on the domains of patient-reported symptoms and quality of life.
The meeting was attended by 72 individuals (from 13 countries) and represented a wide range of sectors including patients, clinicians, methodologists and pharmaceutical companies.
Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)
Schmitt J, Apfelbacher C, Spuls PI, Thomas KS, Simpson EL, Furue M, Chalmers J, Williams HC.
Br J Dermatol 2016 Jul 19. doi: 10.1111/bjd. 14773 (Abstract Link)
POEM a core instrument to measure symptoms in clinical trials: a HOME statement
Spuls PI, Gerbens LA, Simpson E, Apfelbacher CJ, Chalmers JR, Thomas KS, Prinsen CA, von Kobyletzki LB, Singh JA, Williams HC, Schmitt J; HOME initiative collaborators.
Br J Dermatol. 2017 Apr;176(4):979-984. doi:10.1111\bjd.15179 (Abstract Link)